Loading...

APC anti-mouse CD31 Antibody

Pricing & Availability
Clone
390 (See other available formats)
Regulatory Status
RUO
Other Names
PECAM-1, EndoCAM
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
390_APC_072808.jpg
C57BL/6 splenocytes stained with 390 APC
  • 390_APC_072808.jpg
    C57BL/6 splenocytes stained with 390 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
102409 25 µg 113 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
102410 100 µg 320 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD31 is a 130-140 kD glycoprotein, also known as platelet endothelial cell adhesion molecule (PECAM-1) and EndoCAM. It is a member of the Ig superfamily, expressed on endothelial cells, platelets, granulocytes, monocytes/macrophages, dendritic cells, and T and B cell subsets, and is critical for cell-cell interactions. The primary ligands for CD31 have been reported to be CD38 and the vitronectin receptor (αv β3 integrin, CD51/CD61). Other reported functions of CD31 are neutrophil emigration to sites of inflammation and angiogenesis.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C3H/HeJ mouse hematopoietic progenitor cell line 3
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Anti-mouse CD31 clones 390 and MEC13.3 bind to their respective non-overlapping epitopes in IgD2 of CD31.8 Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo blocking of CD31-mediated cell-cell interactions1-4, and immunohistochemical staining5,6,7 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections. Special Note: This antibody is not recommended for formalin-fixed paraffin-embedded sections. The LEAF™ purified antibody (Endotoxin < 0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 102412).

Application References

(PubMed link indicates BioLegend citation)
  1. Baldwin HS, et al. 1994. Development 120:2539. (IP, Block)
  2. DeLisser HM, et al. 1997. Am. J. Pathol. 151:671. (Block)
  3. Rosenblum WI, et al. 1996. Stroke 27:709. (Block)
  4. Iguchi A, et al. 1997. Cell Struct. Funct. 22:357. (Block)
  5. Wyder L, et al. 2000. Cancer Res. 60:4682. (IHC)
  6. Wiewrodt R, et al. 2002. Blood 99:912. (IHC)
  7. McQualter JL, et al. 2009. Stem Cells. 27:623. (IHC) PubMed
  8. Chacko AM, et al. 2012. PLoS One 7:e34958.
  9. Greineder CF, et al. 2013. PLoS One. 14:80110. PubMed
Product Citations
  1. Hudson WH, et al. 2020. Immunity. 51(6):1043-1058.e4.. PubMed
  2. Yang D, et al. 2022. Cell. 185:1905. PubMed
  3. Ferrao Blanco MN, et al. 2022. Br J Pharmacol. 179:2771. PubMed
  4. Kozuki S, et al. 2022. Genes Cells. 27:192. PubMed
  5. Lloyd-Lewis B, et al. 2022. Cell Rep. 38:110461. PubMed
  6. Tsumita T, et al. 2022. Int J Cancer. 151:944. PubMed
  7. Kuo CS, et al. 2022. Elife. 11: . PubMed
  8. Chang J, et al. 2023. Research (Wash D C). 6:0120. PubMed
  9. Kalgudde Gopal S, et al. 2023. Nat Commun. 14:3020. PubMed
  10. Gao Q, et al. 2019. J Exp Med. 216:688. PubMed
  11. Wang J, et al. 2019. Front Immunol. 9:3157. PubMed
  12. Leimkühler NB, et al. 2020. Cell Stem Cell. 28:637. PubMed
  13. Cen B, et al. 2021. Oncogene. 40:5984. PubMed
  14. Park M, et al. 2021. BMB Rep. 54:470. PubMed
  15. Yeo S, et al. 2016. Cancer Res . 76: 3397 - 3410. PubMed
  16. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  17. Srivastava N, et al. 2020. FASEB J. 34:12805. PubMed
  18. Hesse J, et al. 2021. eLife. 10:00. PubMed
  19. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  20. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  21. Pal B, et al. 2017. Nat Commun.. 10.1038/s41467-017-01560-x. PubMed
  22. Linehan JL et al. 2018. Cell. 172(4):784-796 . PubMed
  23. Quintana E, et al. 2012. Sci Transl Med. 149:159. PubMed
  24. Eskiocak U, et al. 2016. Nat Commun. 7:12336. PubMed
  25. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  26. Zeng Z, et al. 2022. Oncogene. :. PubMed
  27. Chu X, et al. 2021. Front Cell Dev Biol. 9:671841. PubMed
  28. Sarvi S et al. 2018. Cell chemical biology. 25(12):1456-1469 . PubMed
  29. Long JT, et al. 2022. Elife. 11:. PubMed
  30. Zhang Z, et al. 2021. Exp Dermatol. 30:102. PubMed
  31. Yang T, et al. 2022. Antioxidants (Basel). 11:. PubMed
  32. Maroni G, et al. 2019. Int J Mol Sci. 20. PubMed
  33. Carmody C et al. 2019. Endocrinology. 160(5):1205-1222 . PubMed
  34. Fu NY, et al. 2018. Dev Cell. 47:629. PubMed
  35. Yeo SK, et al. 2020. eLife. 9:e58810.. PubMed
  36. Ko HJ, et al. 2020. Front Immunol. 1897:11. PubMed
  37. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  38. Hendee K, et al. 2021. Aging (Albany NY). 13:7781. PubMed
  39. Santini MP, et al. 2020. Cell Rep. 30:555. PubMed
  40. Wang X, et al. 2018. Nat Commun. 9:551. PubMed
  41. Shen B, et al. 2019. Elife. 8:e42274. PubMed
  42. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  43. DeVilbiss AW, et al. 2021. eLife. 10:00. PubMed
  44. Kalinina A, et al. 2022. PLoS One. 17:e0250752. PubMed
  45. Phansalkar R, et al. 2021. Elife. 10:. PubMed
  46. Kim KS, et al. 2022. JCI Insight. 7:. PubMed
  47. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  48. Pal B, et al. 2021. Breast Cancer Res. 23:69. PubMed
  49. Ouadah Y, et al. 2019. Cell. 179:403. PubMed
  50. Dumm RE, et al. 2020. Cell Reports. 32(9):108103.. PubMed
  51. Longchamp A, et al. 2018. Cell. 173:117. PubMed
RRID
AB_312904 (BioLegend Cat. No. 102409)
AB_312904 (BioLegend Cat. No. 102410)

Antigen Details

Structure
Ig superfamily, 130-140 kD
Distribution

Endothelial cells, platelets, granulocytes, monocytes/macrophages, dendritic cells, T and B cell subsets

Function
Adhesion
Ligand/Receptor
CD38, αV/β3 integrin
Cell Type
B cells, Dendritic cells, Endothelial cells, Granulocytes, Macrophages, Monocytes, Neutrophils, Platelets, T cells
Biology Area
Angiogenesis, Cell Adhesion, Cell Biology, Immunology, Neuroinflammation, Neuroscience
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. DeLisser HM, et al. 1994. Immunol. Today 15:490.
3. Newman PJ, et al. 1990. Science 247:1219.

Gene ID
18613 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD31
Specificity Alt (DOES NOT SHOW ON TDS):
CD31
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD31 on UniProt.org
Go To Top Version: 2    Revision Date: 07.19.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account